Open access
Jan 2026
Serum Metabolomic Profiling Reveals Potential Mechanisms and Biomarkers of Seladelpar Treatment in Patients With Primary Biliary Cholangitis
Targeted metabolomics confirmed seladelpar′s impact on carnitine and acylcarnitines, which facilitate fatty acid β‐oxidation, and highlighted potential pathways for future exploration in the treatment of PBC and its symptoms.
Yun-Jung Choi, Andrew J. Schwab, James Lim et al.
· PPAR Research · 0 citations